Fortis Healthcare to hold 30th AGM on Aug 11, 2026; proposes ₹1 dividend
Fortis Healthcare will hold its 30th AGM on August 11, 2026, via VC/OAVM. The company proposes a final dividend of ₹1 per equity share for FY 2025-26. Key agenda items include director appointments, auditor remuneration, and approval for independent director commission up to ₹77.17 lakhs annually. Dr. Ashutosh Raghuvanshi's re-appointment as MD & CEO for two years from March 19, 2027, with remuneration up to ₹11.23 crore, is also proposed.
The AGM involves decisions on dividend, director appointments, and remuneration, which are material for corporate governance and shareholder relations. The proposed dividend and re-appointment of key management personnel have a direct impact on stakeholders.
The announcement is a routine corporate event (AGM notice) with standard agenda items including dividend declaration and director appointments/remuneration. While these are important, they do not indicate a significant positive or negative shift in the company's performance or outlook.
Fortis Healthcare Limited has announced its 30th Annual General Meeting (AGM) will be held on Tuesday, August 11, 2026, at 12:00 PM IST through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company has fixed Friday, July 03, 2026, as the cut-off date to determine shareholder eligibility for receiving the AGM notice and Annual Report for the financial year 2025-26.
The AGM agenda includes the adoption of Audited Financial Statements (Standalone and Consolidated) for the year ended March 31, 2026, and the declaration of a final dividend of ₹1 per equity share. Additionally, shareholders will vote on the appointment of directors, ratification of remuneration for Cost Auditors M/s. Jitender, Navneet & Co. up to ₹2,95,000, and the approval for payment of commission to Independent Directors for a period of three years from April 1, 2027, to March 31, 2030. The proposed commission for each Independent Director is up to ₹77,17,500 per annum, and up to ₹1,95,00,000 per annum for the Chairman of the Board (if an Independent Director).
Furthermore, the re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director (designated as Managing Director & CEO) for a period of two years effective March 19, 2027, is on the agenda. His remuneration is proposed to be up to ₹11,23,46,000 per annum, with provisions for increments, variable pay, and perquisites. The company is also seeking approval for the payment of ₹1,95,00,000 to Mr. Leo Puri as Non-Executive Independent Chairperson for FY 2025-26, which exceeds 50% of the total remuneration payable to all Non-Executive Directors.
The Annual Report and AGM Notice are available on the company's website. The company provides facilities for remote e-voting, commencing from Thursday, August 06, 2026, at 9:00 AM IST, and ending on Monday, August 10, 2026, at 5:00 PM IST. The cut-off date for determining eligibility for voting on AGM resolutions is Tuesday, August 04, 2026.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.